G1SK34:BVMF
Gsk Plc Bdr
၅၀.၅၀ R$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၁၆, GMT-၃ ၁၆:၅၆:၀၀ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for G1SK34...
Open
၅၀.၁၀ R$
High
၅၀.၇၅ R$
Low
၅၀.၁၀ R$
Mkt. cap
ဋေ ၁.၀၁ သ
Avg. vol.
၂၁၄.၀၀
Volume
၁၆၅.၀၀
52-wk high
၆၃.၂၄ R$
52-wk low
၄၆.၁၅ R$
Shares outstanding
၄၃၁.၆၃ ဋေ
No. of employees
၇ သောင်း
Open
၅၀.၁၀ R$
High
၅၀.၇၅ R$
Low
၅၀.၁၀ R$
Mkt. cap
ဋေ ၁.၀၁ သ
Avg. vol.
၂၁၄.၀၀
Volume
၁၆၅.၀၀
52-wk high
၆၃.၂၄ R$
52-wk low
၄၆.၁၅ R$
Shares outstanding
၄၃၁.၆၃ ဋေ
No. of employees
၇ သောင်း
News stories
From web sources and news partners
Foreign Policy Journal
·
ပြီးခဲ့သည့် ၁ ရက်
GSK (NYSE: GSK) Share Price Rises After CEO And CFO Boost Personal Holdings As Technical Pressure Persists
The Globe and Mail
·
ပြီးခဲ့သည့် ၁ ရက်
UBS Keeps Their Hold Rating on GlaxoSmithKline (GSK)
Traders Union
·
ပြီးခဲ့သည့် ၂ ရက်
GSK shares technical analysis: Overbought conditions highlight reversal setup
JournalArta
·
ပြီးခဲ့သည့် ၂ ရက်
GSK Stock Gains 2.89% on Thursday: Full Details
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About Gsk Plc Bdr
CEOEmma Walmsley | Emma Walmsley
Employees၆.၆၈ သောင်း
Founded၂၀၀၀ ဒီ ၂၇
Headquarters-
Sector-
Websitegsk.com